Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | 5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled | Starlite/ChEMBL | References |
Homo sapiens | dopamine receptor D2 | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | Zn-finger in Ran binding protein and others, putative | 0.0032 | 0.1582 | 1 |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.0032 | 0.1582 | 0.2514 |
Toxoplasma gondii | SWIB/MDM2 domain-containing protein | 0.0089 | 0.5558 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0153 | 1 | 1 |
Plasmodium vivax | hypothetical protein, conserved | 0.0089 | 0.5558 | 0.5 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.0089 | 0.5558 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.1582 | 0.1582 |
Leishmania major | hypothetical protein, conserved | 0.0032 | 0.1582 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.1582 | 0.1582 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.1582 | 0.1582 |
Echinococcus granulosus | SWI:SNF matrix associated | 0.0089 | 0.5558 | 0.4723 |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.0032 | 0.1582 | 0.2514 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.1582 | 0.1582 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others/FYVE zinc finger, putative | 0.0032 | 0.1582 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0032 | 0.1582 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0089 | 0.5558 | 0.5 |
Onchocerca volvulus | 0.0089 | 0.5558 | 1 | |
Trypanosoma brucei | hypothetical protein, conserved | 0.0032 | 0.1582 | 1 |
Trypanosoma cruzi | mitochondrial RNA binding complex 1 subunit, putative | 0.0032 | 0.1582 | 1 |
Trypanosoma cruzi | WLM domain containing protein, putative | 0.0032 | 0.1582 | 1 |
Trypanosoma cruzi | mitochondrial RNA binding complex 1 subunit, putative | 0.0032 | 0.1582 | 1 |
Brugia malayi | brahma associated protein 60 kDa | 0.0089 | 0.5558 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.1582 | 0.1582 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0032 | 0.1582 | 1 |
Brugia malayi | brahma associated protein 60 kDa | 0.0089 | 0.5558 | 1 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0089 | 0.5558 | 0.4723 |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.0032 | 0.1582 | 0.2514 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0089 | 0.5558 | 0.4723 |
Loa Loa (eye worm) | CYP4Cod1 | 0.0012 | 0.0247 | 0.0247 |
Plasmodium vivax | SWIB/MDM2 domain-containing protein, putative | 0.0089 | 0.5558 | 0.5 |
Echinococcus multilocularis | serotonin receptor | 0.0153 | 1 | 1 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0012 | 0.0247 | 0.0247 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.0089 | 0.5558 | 1 |
Brugia malayi | YY1-associated factor 2 | 0.0032 | 0.1582 | 0.2514 |
Echinococcus granulosus | Upstream activation factor subunit UAF30 | 0.0089 | 0.5558 | 0.4723 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others, putative | 0.0032 | 0.1582 | 1 |
Schistosoma mansoni | brg-1 associated factor | 0.0089 | 0.5558 | 0.4723 |
Chlamydia trachomatis | SWIB complex protein | 0.0089 | 0.5558 | 0.5 |
Schistosoma mansoni | biogenic amine (5HT) receptor | 0.0153 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0089 | 0.5558 | 0.4723 |
Brugia malayi | SWIB/MDM2 domain containing protein | 0.0089 | 0.5558 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0032 | 0.1582 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0032 | 0.1582 | 1 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0012 | 0.0247 | 0.0247 |
Chlamydia trachomatis | DNA topoisomerase I | 0.0089 | 0.5558 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0032 | 0.1582 | 1 |
Loa Loa (eye worm) | SWIB/MDM2 domain-containing protein | 0.0089 | 0.5558 | 0.5558 |
Echinococcus multilocularis | Upstream activation factor subunit UAF30 | 0.0089 | 0.5558 | 0.4723 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0032 | 0.1582 | 1 |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.0032 | 0.1582 | 0.2514 |
Toxoplasma gondii | DNA topoisomerase domain-containing protein | 0.0089 | 0.5558 | 1 |
Loa Loa (eye worm) | brahma associated protein | 0.0089 | 0.5558 | 0.5558 |
Mycobacterium ulcerans | cytochrome P450 185A4 Cyp185A4 | 0.0012 | 0.0247 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0032 | 0.1582 | 1 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0089 | 0.5558 | 0.4723 |
Schistosoma mansoni | hypothetical protein | 0.0089 | 0.5558 | 0.4723 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0032 | 0.1582 | 1 |
Trypanosoma brucei | mitochondrial RNA binding complex 1 subunit | 0.0032 | 0.1582 | 1 |
Echinococcus multilocularis | serotonin receptor | 0.0153 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0089 | 0.5558 | 0.4723 |
Loa Loa (eye worm) | hypothetical protein | 0.0153 | 1 | 1 |
Trypanosoma cruzi | WLM domain containing protein, putative | 0.0032 | 0.1582 | 1 |
Trypanosoma brucei | Zn-finger in Ran binding protein and others/FYVE zinc finger, putative | 0.0032 | 0.1582 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (binding) | = 0.95 nM | Displacement of [3H]8OH-DPAT from human 5HT1A receptor expressed in CHO -K1 cell membrane after 60 mins by liquid scintillation counting | ChEMBL. | 22607670 |
Ki (binding) | = 29.7 nM | Displacement of [3H]spiperone from human D2 DA receptor expressed in CHO cell membrane after 60 mins by liquid scintillation counting | ChEMBL. | 22607670 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.